World-Class Cancer Treatment in Shanghai
Shanghai is one of Asia's premier destinations for cancer treatment, offering international patients access to the full spectrum of modern medical oncology — from precision targeted therapy and immunotherapy to chemotherapy, clinical trials, and comprehensive multidisciplinary cancer care. The city's leading oncology departments are affiliated with Shanghai's top academic medical universities and are equipped with the latest molecular diagnostics, next-generation sequencing (NGS) platforms, and access to novel agents that may not yet be available in patients' home countries. Whether you are seeking a second opinion on your cancer diagnosis, access to a specific targeted therapy or immunotherapy, or enrollment in a clinical trial, CMCS connects international patients with the right oncologist at the right institution in Shanghai.
What Cancers Are Treated?
Shanghai's leading medical oncology centers offer comprehensive systemic treatment for all major cancer types, including:
- Lung cancer — EGFR, ALK, ROS1, KRAS targeted therapy; PD-1/PD-L1 immunotherapy; small cell lung cancer
- Gastric and colorectal cancer — HER2-targeted therapy, VEGF inhibitors, immunotherapy, FOLFOX/FOLFIRI regimens
- Liver cancer (HCC) — sorafenib, lenvatinib, atezolizumab + bevacizumab, TACE coordination
- Breast cancer — HER2-targeted therapy (trastuzumab, pertuzumab, T-DM1, T-DXd), CDK4/6 inhibitors, PARP inhibitors
- Pancreatic cancer — FOLFIRINOX, gemcitabine + nab-paclitaxel, KRAS G12C inhibitors
- Lymphoma and hematological malignancies — R-CHOP, CAR-T cell therapy, BTK inhibitors, BCL-2 inhibitors
- Thyroid cancer — radioiodine therapy, lenvatinib, sorafenib for refractory cases
- Kidney cancer (RCC) — sunitinib, pazopanib, nivolumab + ipilimumab, cabozantinib
- Bladder cancer — platinum-based chemotherapy, PD-1/PD-L1 immunotherapy, enfortumab vedotin
- Prostate cancer — enzalutamide, abiraterone, PARP inhibitors, PSMA-targeted therapy
- Rare cancers and tumors of unknown primary — NGS-guided precision oncology
Why International Patients Choose Shanghai for Cancer Treatment
International patients choose Shanghai for cancer treatment for several compelling reasons. First, access to novel targeted therapies and immunotherapy agents — including drugs approved in China before Western markets, and vice versa — means patients can access treatment options not available at home. Second, Shanghai's academic medical centers have extensive experience with Asian cancer subtypes — particularly gastric cancer, liver cancer, and EGFR-mutant lung cancer — that are more prevalent in Asia and for which Chinese oncologists have unparalleled clinical expertise. Third, the cost of cancer treatment in Shanghai — including chemotherapy, targeted therapy, and immunotherapy — is significantly lower than in Western countries, making treatment financially accessible for patients who cannot afford care at home. Finally, Shanghai's oncology centers offer access to clinical trials of novel agents that may not be available elsewhere.
How CMCS Arranges Your Oncology Consultation
CMCS manages every aspect of your cancer care journey in Shanghai. Here's how we help:
- Initial Consultation: Contact CMCS and share your pathology reports, molecular testing results, imaging, and treatment history.
- Case Review: Our team reviews your case and identifies the most appropriate oncologist and institution for your specific cancer type and molecular profile.
- Appointment Booking: We coordinate directly with the hospital to secure your consultation at a convenient time.
- Pre-Visit Preparation: We advise on which pathology materials, molecular test results, and imaging to bring or send in advance.
- On-the-Day Support: A CMCS coordinator accompanies you through registration, consultation, and any same-day blood tests or assessments.
- Treatment Coordination: If treatment in Shanghai is recommended, CMCS helps coordinate hospital admission, chemotherapy scheduling, and ongoing care logistics.
What to Prepare Before Your Visit
To ensure the most productive oncology consultation, please prepare:
- Pathology and biopsy reports (original slides or digital scans preferred)
- Molecular pathology: NGS panel results, specific mutation testing (EGFR, ALK, HER2, KRAS, BRCA, MSI/MMR, PD-L1, TMB)
- Recent imaging: CT scan of chest/abdomen/pelvis, PET-CT if available, MRI for brain or bone metastases
- Tumor markers relevant to your cancer type
- Records of all prior treatment: chemotherapy regimens, targeted therapy, immunotherapy, radiotherapy, surgery
- Treatment response assessments and progression notes
- A full list of current medications
- Your passport and travel/health insurance documents
What to Expect on the Day
Shanghai's leading medical oncology centers operate as comprehensive multidisciplinary cancer centers with weekly tumor board meetings, access to NGS molecular profiling, clinical trial coordinators, and dedicated infusion centers for chemotherapy and immunotherapy administration. Your consultation will involve a thorough review of your molecular profile and clinical history, followed by a clear discussion of treatment options — including standard-of-care regimens, novel targeted agents, and clinical trial eligibility. CMCS will ensure all communication is clear and that you leave with a complete understanding of your cancer status and the recommended treatment plan.
Contact CMCS to Get Started
Ready to book your oncology consultation in Shanghai? Contact our team today:
CMCS is your trusted medical concierge partner in Shanghai — making world-class Chinese healthcare accessible to international patients.
0 comentarios